The cost effectiveness of imatinib mesylate was estimated by extrapolating long-term survival and costs from the pivotal multicentre trial of 147 patients with advanced GIST receiving imatinib ...
Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...
Clin Drug Invest. 2007;27(2 ... and suggest strongly that management of GIST with imatinib mesylate according to NCCN guidelines is also cost effective.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback